Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.
Shares outstanding over time
Latest: 4.6M shares as of Sep 18, 2026 (10-Q).⊙
EVIDENCE — filed/published fact
SourceSEC XBRL, cover-page share count
Fielddei:EntityCommonStockSharesOutstanding
As of2026-09-18
HowThe newest cover-page count as filed, whatever its age. The float checker applies a 200-day freshness rule and sets this beside the balance-sheet count.
Share count fell from 24.1M to 773,975 between Sep 14, 2023 and Oct 2, 2023, a pattern consistent with a reverse split (roughly 1-for-31); simultaneous issuance can skew the raw ratio, so confirm in the filings. The red bar marks the cliff.
Balance-sheet fair value of warrants: $3.7M as of Apr 30, 2024.
Rough fully diluted estimate: 16.6M = 4.6M O/S + 12.0M warrant shares. An estimate, not a filing figure: it ignores converts, options and RSUs, and the two inputs carry different as-of dates.
Convertible notes
No convertible-note facts tagged in the 10-Q filed Sep 22, 2026. If convertible notes exist, their terms live in exhibit prose for this filer and are not parsed; absence of a tag is not proof of absence. The exhibits are the ground truth.
Fully diluted build-up
Shares outstanding plus every potential-share instrument the filer tagged in XBRL, each at its own as-of date. An estimate assembled from filed figures, not a filing figure itself.
Shares outstanding
4.6M
Sep 18, 2026
+ Warrants (aggregate, as tagged) (if exercised)
12.0M
Oct 31, 2021
Fully diluted estimate
16.6M
+262.5% vs O/S
Still excluded, because the filer does not tag them in countable form: employee options and RSUs, any instrument living only in exhibit prose, and instruments above missing a share count. Inputs carry different as-of dates, shown per row. Each figure traces to the tranche and note tables above and their cited filings.
Registrations and offerings
S-3Jan 10, 2025no structured fee exhibit in this filing (predates fee-data XBRL or fee deferred)filing →
S-1Oct 11, 2024no structured fee exhibit in this filing (predates fee-data XBRL or fee deferred)filing →
S-1May 28, 2024no structured fee exhibit in this filing (predates fee-data XBRL or fee deferred)filing →
Last 12 months: 2 executed · 0 registered.
EXECUTEDJan 15, 2026Unregistered share sale disclosed (8-K item 3.02)8-K →
EXECUTEDDec 22, 2025Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)424B5 →
EXECUTEDAug 22, 2025Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)424B5 →
EXECUTEDJul 11, 2025Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)424B5 →
UPDATEJul 11, 2025Prospectus update — often a resale registration, not necessarily new capital424B3 →
EXECUTEDJul 2, 2025Unregistered share sale disclosed (8-K item 3.02)8-K →
EFFECTIVEJun 11, 2025SEC declared a registration effective — selling can beginEFFECT →
REGISTEREDMay 29, 2025S-3/A registration — capacity to sell shares, not a sale yetS-3/A →
REGISTEREDMar 5, 2025S-3/A registration — capacity to sell shares, not a sale yetS-3/A →
REGISTEREDFeb 14, 2025S-3/A registration — capacity to sell shares, not a sale yetS-3/A →
REGISTEREDJan 10, 2025S-3 registration — capacity to sell shares, not a sale yetS-3 →
EXECUTEDNov 25, 2024Unregistered share sale disclosed (8-K item 3.02)8-K →
Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.